If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

Share Price is delayed by 15 minutes
Get Live Data
4.63    0.00 (0.00%)
Bid:
4.74
Ask:
5.20
Spread: 0.46 (9.705%)
Market Cap: £7.54m
TAN Live PriceLast checked at - London Stock Exchange

Intraday Tanfield Share Chart

Snorkel Investment Update

24 Oct 2019 14:44

RNS Number : 0663R
Tanfield Group PLC
24 October 2019
 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

Snorkel Investment Update

 

The Board of Tanfield (the "Board") is updating the market regarding legal proceedings that have recently been served on Ward Hadaway, the Company's former solicitor, in relation to the firm's role in the transfer of Tanfield's Powered Access Division to Snorkel International Holdings LLC ("Snorkel") (the "Joint Venture") in October 2013.

 

Following the Joint Venture between Tanfield and Xtreme Manufacturing LLC ("Xtreme"), a company owned by Don Ahern of Ahern Rentals Inc ("Ahern"), Tanfield became a 49% shareholder in the equity of Snorkel.

 

As reported in the Snorkel Investment Update on 22 October 2019, Snorkel and SKL Holdings LLC ("SKL"), the 51% shareholder in Snorkel, have brought a claim against Tanfield in Nevada in which they allege that the Company has refused to comply with its contractual obligations relating to a purported call option which sought to acquire the Company's membership interest in Snorkel for an option price of $0 (nil) as well as purporting that payment of the priority amount and preferred return (collectively the "Preferred Interest") is not required (the "US Litigation").

 

As a result of the issues arising from the US Litigation, Tanfield has been seeking to preserve its position against Ward Hadaway as, depending on the outcome of the US Litigation, the Company may need to hold the firm to account for its role in and/or advice to Tanfield in relation to the Joint Venture transfer. Due to time limitation issues, and because a suitable Standstill Agreement which would have fully protected the Company could not be agreed, it became necessary for the Company to issue and serve a claim against Ward Hadaway in the English High Court in order to ensure that the Company's rights were fully protected pending the outcome of the US Litigation. It is the intention of the Board to seek a stay of the claim, pending the outcome of the US Litigation, as the outcome of that litigation will have a direct and material impact on the Company's claim, including the quantum of the claim.

 

At this stage it is unknown if (and when) a stay will be obtained, but the Board of Tanfield continues to seek advice and will vigorously protect its position, if necessary, and will provide further updates to shareholders as and when appropriate.

 

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson  

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Lydia Zychowska 020 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDLLFSVILLSFIA
Date   Source Headline
30th Jun 20264:33 pmRNSHolding(s) in Company
9th Jun 20264:00 pmRNSHolding(s) in Company
22nd May 20268:28 amRNSResult of AGM
2nd Apr 20267:00 amRNSFinal 2025 Results & AGM Notice
1st Apr 20267:00 amRNSSnorkel Investment Update
3rd Mar 20264:02 pmRNSSnorkel Investment Update
26th Nov 20257:00 amRNSSnorkel Investment Update
30th Sep 20257:00 amRNSInterim Results for six-month period 30 June 2025
27th Jun 20257:00 amRNSResult of AGM
19th May 20257:00 amRNSSnorkel Investment Update
17th Apr 20257:00 amRNSAnnual Financial Report
7th Feb 20257:00 amRNSSnorkel Investment Update
13th Sep 20247:00 amRNSInterim Results for the six-months to 30 June 2024
16th Aug 202412:39 pmRNSSnorkel Investment Update
7th Aug 20241:59 pmRNSSnorkel Investment Update
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
14th Jun 20247:00 amRNSResult of AGM
25th Apr 20249:14 amRNSReplacement Final Results for year end 31 Dec 2023
25th Apr 20247:00 amRNSFinal Results for the year ended 31 Dec 2023
20th Nov 20231:01 pmRNSSnorkel Investment Update
17th Aug 20237:00 amRNSSnorkel Investment Update
24th Jul 20237:00 amRNSInterim Results for the six-months to 30 June 2023
2nd Jun 20237:00 amRNSResult of AGM
18th May 20237:00 amRNSSnorkel Investment Update
21st Apr 20237:00 amRNSFinal Results and Notice of AGM
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSSnorkel Investment Update
15th Nov 20229:54 amRNSSnorkel Investment Update
18th Oct 20224:40 pmRNSSecond Price Monitoring Extn
18th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 202210:48 amRNSSnorkel Investment & Legal Proceeding Update
14th Oct 20221:17 pmRNSSnorkel Investment & Legal Proceeding Update
9th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
24th Aug 20227:00 amRNSSnorkel Investment & Loan Subscription Update
3rd Aug 20228:46 amRNSResult of AGM
19th Jul 20224:36 pmRNSPrice Monitoring Extension
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
26th May 202211:44 amRNSSnorkel Investment Update
24th May 20227:00 amRNSLoan Note Instrument
12th May 20224:40 pmRNSSecond Price Monitoring Extn
12th May 20224:35 pmRNSPrice Monitoring Extension
10th May 20227:00 amRNSSnorkel Investment & Legal Proceedings Update
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 202212:56 pmRNSLoan Subscription Update
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
18th Feb 20224:35 pmRNSPrice Monitoring Extension
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSSnorkel Legal Proceedings Update
28th Jan 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.